失代偿期乙型肝炎肝硬化患者营养状况分析

doi:10.3969/j.issn.1672-5069.2017.02.030

Abstract

Wang Zhichong， Song Fengbin. Assessment of nutritional status in patients with decompensated liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 236-237.

[1] Kalaitzakis E， Simrén M， OIsson R， et a1.Gastrointestinal symptoms in patients with liver cirrhosis:associations with nutritional status and health-related quality of life. Scand J Gastroenterol，2006，41（12）:1464-1472.
[2] 任建安，黎介寿.肝硬变病人的营养支持.中国实用外科杂志，2010，21（10）:620-622.
[3] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2015年版）.实用肝脏病杂志，2016，19（3）：Ⅴ-ⅩⅩⅢ.
[4] Campillo B， Richardet JP， Bories PN. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol，2006，30（10）:1137-1143.
[5] 国际生命科学学会中国办事处中国肥胖问题工作组联合数据汇总分析协作组.中国成人体质指数分类的推荐意见简介.中华预防医学杂志，2001，35（5）:349-350.
[6] 陈艳秋，孙建琴，宗敏，等.住院病人营养不良患病率调查与分析.肠外与肠内营养，2006，13（1）:29-32.
[7] 张宝凤.营养治疗对肝硬化患者预后的疗效观察.临床和实验医学杂志，2008，7（6）:27-28.
[8] 王飞，王燕，裴容，等.北京佑安医院住院肝硬化患者营养风险状况.中华临床医师杂志（电子版），2013，7（17）:8031-8033.
[9] 周永健，余祖江.肝硬化患者的营养评价与营养治疗.世界华人消化杂志，2014，22（31）: 4750-4756.
[10] Seres DS. Surrogate nutrition markers， malnutrition， and adequacy of nutrition support. Nutr Clin Pract，2005，20（3）:308-313.
[11] 孔明，段钟平.终末期肝病患者营养状况评价与营养风险筛查方法.实用肝脏病杂志，2011，14（6）:482-486.
[12] 金爱华，杨华升.慢性肝病营养评估研究进展.中西医结合肝病杂志，2013，23（5）:318-320.
[13] Guglielmi FW， Panella C， Buda A，et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology（SIGE）. Dig Liver Dis，2005，37 （9） :681-688.
[14] 郭迎迎，褚燕君.营养风险筛查2002对肝硬化患者营养评估的可行性探讨.河南医学研究，2011，20（1）:58-60.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	. [J]. Journal of Practical Hepatology, 2019, 22(5): 624-635.
[6]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[7]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[8]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[11]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[12]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[13]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[14]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[15]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.

Assessment of nutritional status in patients with decompensated liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments